ArticleBlood cancer journal2025

Clinical course, risk factors and mitigating strategies for Immune effector cell-associated late onset neurotoxicities after ciltacabtagene autoleucel CAR-T in multiple myeloma.

Kenneth J C Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.